Eutropics Pharmaceuticals
Cambridge, US · Founded 2005 · Delaware corporation · 6 employees on LinkedIn
Founders & leadership
MC
Michael CardoneExecutive
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 of 2 rounds · 2021–2024
▶$350KofferedJan 2024 · PharmaceuticalsRule 506(b)
▶$350KofferedJan 2024 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael CardoneExecutive Officer, Director
- Offering amount
- $350K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$350KraisedNov 2021 · 5 investors · PharmaceuticalsRule 506(b)
▶$350KraisedNov 2021 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael CardoneExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $350K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Eutropics Pharmaceuticals raised?
- Eutropics Pharmaceuticals has disclosed $350K raised across 1 of its 2 known rounds.
- Where is Eutropics Pharmaceuticals headquartered?
- Eutropics Pharmaceuticals is headquartered in Cambridge, US.